Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Tatsuya FukaseTomotaka DohiTakuma KoikeHidetoshi YasudaMitsuhiro TakeuchiNorihito TakahashiYuichi ChikataHirohisa EndoShinichiro DoiHiroki NishiyamaIwao OkaiHiroshi IwataShinya OkazakiKatsumi MiyauchiHiroyuki DaidaTohru MinaminoPublished in: ESC heart failure (2021)
Long-term β-blocker use was significantly associated with an increased risk of adverse cardiovascular events in elderly patients with CAD without MI or systolic HF. In particular, the chronotropic incompetence action of β-blockers could increase the risk of admission for HF in elderly patients with CAD without MI and systolic HF, and the present findings warrant further investigation.
Keyphrases
- coronary artery disease
- cardiovascular events
- percutaneous coronary intervention
- left ventricular
- heart failure
- acute heart failure
- angiotensin converting enzyme
- blood pressure
- coronary artery bypass grafting
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- cardiovascular disease
- emergency department
- angiotensin ii
- middle aged
- type diabetes
- coronary artery bypass
- electronic health record